Date: March 16, 2020
Category: COVID-19 Response

    on Social:

SAMHSA: COVID-19 Guidance for Opioid Treatment Programs

The Substance Abuse and Mental Health Services Administration (SAMHSA) provides guidance on pharmacotherapy for opioid use disorder availability in circumstances in which patients may be exposed to highly contagious infectious agents (such as COVID-19).

View Resource